AZD0120 (GC012F), a BCMA/CD19 dual-targeting fastcar T-cell therapy, demonstrates potent preclinical efficacy in multiple myeloma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Huan Shi, Wenjie Yin, Hua Zhang, Jiaping He, Suying Zhang, Tao Wang, Xiaoyan Jiang, Jiajing Wen, Guangyao Zhu, Wei Cao, Mark Cobbold, Lianjun Shen
Institution: AstraZeneca (United States)
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108439679
Cites:
Cited by:
Related to: